磁共振扩散加权成像改善可切除胰腺癌患者CT上局灶性肝脏病变的评估
在167例经分期MDCT评估为潜在可切除胰腺导管腺癌的患者中,联合MDCT与MRI(含DWI)较单独MDCT显著提高肝脏局灶性病变诊断效能(读者平均FOM 0.94 vs 0.86,p=.028),对CT上≤1 cm的不确定或可疑转移病变诊断增益更高。
要点
- 联合MDCT与MRI(含DWI)较单独MDCT显著提高肝脏局灶性病变诊断效能(FOM 0.94 vs 0.86,p=.028)。
- CT阴性组MRI诊断增益1.5-2.3%,CT不确定组10.5-13.6%,CT可疑转移组8.3-26.7%。
- 所有CT假阳性和假阴性病变均≤1 cm。
核心结论
- 在潜在可切除胰腺导管腺癌患者中,加用MRI(含DWI)可显著提高肝脏局灶性病变定性诊断效能,尤其对≤1 cm的CT不确定或可疑转移病变,有助于确定合适的手术候选者。
研究设计与样本
- 研究纳入167例经分期MDCT评估为潜在可切除的胰腺导管腺癌患者,由两名读者独立对MDCT组及MDCT联合MRI组进行肝脏局灶性病变特征评分(良性、不确定或转移)。
关键影像表现/征象
- 联合MDCT与MRI组读者平均品质因子(FOM)为0.94,显著高于单独MDCT组的0.86(p=.028)。
- CT阴性组MRI诊断增益为1.5-2.3%(读者1为2/133,读者2为3/133)。
- CT不确定组MRI诊断增益为10.5-13.6%(读者1为2/19,读者2为3/22)。
- CT可疑转移组MRI诊断增益为8.3-26.7%(读者1为1/12,读者2为4/15)。
- 所有CT假阳性和假阴性病变均≤1 cm。
临床应用与阅片要点
- 联合MDCT与MRI(含DWI)判读可提高肝脏局灶性病变诊断效能,尤其对CT上≤1 cm的不确定或可疑转移病变。
- 联合判读可减少不确定肝脏病变的出现频率。
- 对潜在可切除胰腺导管腺癌患者,联合MRI有助于更有信心地确定手术候选者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate added value of MRI to preoperative staging MDCT for evaluation of focal liver lesions (FLLs) in potentially resectable pancreatic ductal adenocarcinomas (PDACs).
MATERIALS AND METHODS: In patients with potentially resectable PDACs after staging MDCT (n=167), characteristics of FLLs were scored as benign, indeterminate or metastases on an MDCT set and combined MDCT and MRI set by two readers, independently. Size of hepatic lesions was measured and detection rate of hepatic metastasis unsuspected by MDCT and diagnostic yield of MRI for FLLs were assessed.
RESULTS: Reader-averaged figure-of-merit (FOM) of the combined set was significantly higher than that of MDCT alone (0.94 vs. 0.86, p=.028). In the negative-on-CT group, the diagnostic yield of MRI was 1.5-2.3% (2/133 and 3/133 for readers 1 and 2, respectively). In the indeterminate-on-CT group, MRI yield was 10.5-13.6% (2/19 and 3/22) and in patients with suspicious-metastasis-on-CT, 8.3-26.7% (1/12 and 4/15). All lesions with false-positive and false-negative CT findings were ≤1 cm.
CONCLUSION: In potentially resectable PDACs, addition of MRI with DWI can provide significantly better diagnostic performance in characterization of focal liver lesions, especially for small-sized (≤ 1 cm) MDCT-indeterminate or suspicious metastasis lesions, aiding in determination of appropriate operation candidates.
KEY POINTS: • Addition of MRI provides better diagnostic performance in characterization of liver lesions. • Combined interpretation of MRI and MDCT provided less frequent indeterminate liver lesions. • Diagnostic yield of MRI was high in CT-indeterminate or suspicious metastatic lesions. • Operation candidates can be determined with greater confidence in potentially resectable PDACs.
引用
- Jeon SK, Lee JM, Joo I, et al. Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. Eur Radiol. 2018. PMID: 29352379. doi:10.1007/s00330-017-5258-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。